Division of Pediatric Cardiology, NewYork-Presbyterian-Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York, USA.
Section of Pediatric and Congenital Cardiac Surgery, Division of Cardiac, Thoracic and Vascular Surgery, NewYork-Presbyterian-Morgan Stanley Children's Hospital, Columbia University Medical Center, New York, New York, USA.
J Am Coll Cardiol. 2022 Jun 7;79(22):2270-2283. doi: 10.1016/j.jacc.2022.03.374.
For neonates with critical congenital heart disease requiring intervention, transcatheter approaches for many conditions have been established over the past decades. These interventions may serve to stabilize or palliate to surgical next steps or effectively primarily treat the condition. Many transcatheter interventions have evidence-based records of effectiveness and safety, which have led to widespread acceptance as first-line therapies. Other techniques continue to innovatively push the envelope and challenge the optimal strategies for high-risk neonates with right ventricular outflow tract obstruction or ductal-dependent pulmonary blood flow. In this review, the most commonly performed neonatal transcatheter interventions will be described to illustrate the current state of the field and highlight areas of future opportunity.
对于需要介入治疗的危重新生儿先天性心脏病患者，过去几十年已经建立了许多经导管治疗方法。这些介入治疗可稳定病情或姑息手术下一步治疗，也可有效治疗该疾病。许多经导管介入治疗的有效性和安全性具有循证医学证据，这使得它们被广泛接受为一线治疗方法。其他技术也在不断创新，为右心室流出道梗阻或依赖导管的肺血流高危新生儿寻找最佳策略。在这篇综述中，将描述最常进行的新生儿经导管介入治疗，以说明该领域的现状，并强调未来的机会领域。
